Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Hospital Universitario Reina Sofia
Córdoba, EspañaPublications in collaboration with researchers from Hospital Universitario Reina Sofia (1)
2024
-
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy
Behavioral and Brain Functions , Vol. 20, Núm. 1